Literature DB >> 1951325

Successful management of Ph chromosome chronic myelogenous leukemia with leukapheresis during pregnancy.

M S Bazarbashi1, M R Smith, C Karanes, I Zielinski, C R Bishop.   

Abstract

We report the successful management of a 25 year-old woman diagnosed in the second trimester of her pregnancy with chronic myelogenous leukemia (CML). She was treated with leukapheresis until her delivery at 38 weeks of gestation. The procedure was without significant adverse effects on the patient or the fetus. Following induced vaginal delivery, the patient underwent allogeneic bone marrow transplantation from her HLA-matched brother and is presently disease free 13 months following her transplant.

Entities:  

Mesh：

Year:  1991        PMID： 1951325     DOI： 10.1002/ajh.2830380316

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  10 in total

Review 1.  Pregnancies in patients with chronic myeloid leukemia in the era of imatinib.

Authors:  Liang-Piu Koh; Devendra Kanagalingam
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

2.  Cancer in pregnancy: maternal-fetal conflict.

Authors:  F S Oduncu; R Kimmig; H Hepp; B Emmerich
Journal:  J Cancer Res Clin Oncol       Date:  2003-03-18       Impact factor: 4.553

Review 3.  Management of chronic myeloid leukemia in the setting of pregnancy: when is leukocytapheresis appropriate? A case report and review of the literature.

Authors:  Elizabeth M Staley; Sierra C Simmons; Alexander Z Feldman; Robin G Lorenz; Marisa B Marques; Lance A Williams; X Long Zheng; Huy P Pham
Journal:  Transfusion       Date:  2017-12-11       Impact factor: 3.157

4.  Obstetric Complications and Management in Chronic Myeloid Leukemia.

Authors:  Minakshi Rohilla; Rakhi Rai; Uday Yanamandra; Neelam Chaudhary; Pankaj Malhotra; Neelam Varma; Vanita Jain; G R V Prasad; Jasvinder Kalra; Subhash C Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2015-02-26       Impact factor: 0.900

5.  Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy.

Authors:  Monika Conchon; Sabri S Sanabani; Mariana Serpa; Mafalda M Y Novaes; Luciana Nardinelli; Patrícia B Ferreira; Pedro Enrique Dorliac-Llacer; Israel Bendit
Journal:  Adv Hematol       Date:  2010-03-07

Review 6.  A benefit-risk assessment of imatinib in chronic myeloid leukaemia and gastrointestinal stromal tumours.

Authors:  Dominik Wolf; Holger Rumpold
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

7.  A case of chronic myelogenous leukemia in pregnancy characterized by a complex translocation t(9;22;11)(q34;q11.2;q13).

Authors:  Surachit Kumar; Mariya Apostolova; Paul V Woolley
Journal:  Hematol Rep       Date:  2011-11-21

8.  Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study.

Authors:  Monika Conchon; Sabri S Sanabani; Israel Bendit; Fernanda Maria Santos; Mariana Serpa; Pedro Enrique Dorliac-Llacer
Journal:  J Hematol Oncol       Date:  2009-10-06       Impact factor: 17.388

9.  Planned pregnancy in a chronic myeloid leukemia patient in molecular remission.

Authors:  Carolina Pavlovsky; Isabel Giere; Germán Van Thillo
Journal:  Case Rep Hematol       Date:  2012-05-16

10.  The teratogenic effects of imatinib mesylate on rat fetuses.

Authors:  M M El Gendy; A M Kandil; M A Helal; F M Zahou
Journal:  Toxicol Rep       Date:  2015-05-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.